TRAINING OF ACADEMIC UROLOGIC ONCOLOGIST

描述（申请人的描述）：T32 培训的主要目标 德克萨斯大学 M.D. Anderson 泌尿外科资助 癌症中心致力于培养学术泌尿肿瘤学家。部门 在培养年轻医师科学家方面拥有出色的记录 在美国主要学术项目中的责任。在 此外，该系培养了高素质的研究科学家，他们 继续进行泌尿科检查。该计划致力于提供 为代表性不足的少数群体提供研究机会。 本次培训资助的导师（医师科学家和研究人员） 拥有活跃研究实验室并得到外部同行支持的科学家 审查资金）致力于高质量的研究经验 关于泌尿系统癌症。 肿瘤领域存在广泛的机会 生物学、癌基因和抑癌基因调节、化学预防、 信号转导和其他癌症相关研究领域。实验室 经验得到许多其他教育机会的补充。 培训主要提供给完成泌尿外科培训的医生 住院医师实习并致力于学术泌尿外科的职业生涯和三年的 培训（由培训补助金支持的 2 年实验室研究和 1 临床培训年数）。 额外的培训机会是后 博士奖学金包括两年的研究。大学 德克萨斯MD安德森癌症中心大力倡导以下核心使命： 卓越的研究、教育和患者护理。 T32培训补助金 为有抱负的医生提供这种激励性的学术环境 和科学家，并为他们发展成为领导者提供了一个框架 学术泌尿肿瘤学。

DESCRIPTION (Applicant's Description): The primary goal of the T32 training grant in the Department of Urology of the University of Texas M.D. Anderson Cancer Center is to produce academic urological oncologists. The Department has an excellent record of producing young physician-scientists with positions of responsibility in major academic programs in the United States. In addition, the Department has developed high quality research scientists who have continued in urologic investigation. The program is committed to provide research opportunities to individuals of underrepresented minorities. T h e mentors in this training grant(physician-scientists and research scientists with active research laboratories supported by external peer- reviewed funding) are committed to a high quality research experience focused on urologic cancer. A broad range of opportunities is available in tumor biology, oncogene and tumor suppressor gene modulation, chemoprevention, signal transduction, and other cancer-related research areas. The laboratory experience is supplemented by numerous other educational opportunities. Training is primarily offered to physicians who have completed a urological residency and are committed to a career in academic urology and three years of training (2 years of laboratory research supported by the training grant and 1 year of clinical training). An additional training opportunity is a post- doctoral fellowship consisting of two years of research. The University of Texas M.D. Anderson Cancer Center vigorously promotes a core mission of excellence in research, education, and patient care. The T32 training grant makes this stimulating academic environment available to aspiring physicians and scientists and provides a framework for their development into leaders in academic urologic oncology.